Supply Chain Confidentiality Doesn’t Stand “Sunshine Test,” Califf Says In Comments On Drug Shortages
US FDA commissioner takes aim at supplier confidentiality in remarks at ISPE annual meeting. But while greater transparency would help avert individual shortages, better economics for generic drugs are needed to solve the problem, he said.
